Ministry of Health and Welfare Launches 'AX-Sprint' Project

Comprehensive Support for Clinical Validation and Insurance Registration

The government is taking direct action to build a "commercialization expressway" to help artificial intelligence (AI)-based digital medical devices overcome the so-called "Death Valley"—the period between regulatory approval and successful adoption in the field.


On the 17th, at Seoul National University Bundang Hospital in Seongnam, Gyeonggi Province, Professor Yoon Yeonyii of the Department of Cardiology (left) explained to Minister of Health and Welfare Jung Eunkyung the process of measuring patients' echocardiographic indicators and interpreting images using AI-based echocardiography analysis software. Seoul National University Bundang Hospital.

On the 17th, at Seoul National University Bundang Hospital in Seongnam, Gyeonggi Province, Professor Yoon Yeonyii of the Department of Cardiology (left) explained to Minister of Health and Welfare Jung Eunkyung the process of measuring patients' echocardiographic indicators and interpreting images using AI-based echocardiography analysis software. Seoul National University Bundang Hospital.

View original image

On March 31, the Ministry of Health and Welfare announced at a briefing session for the "AI Application Product Rapid Commercialization Support Project" that it will allocate a total budget of 8 billion won to lower market entry barriers for digital medical device manufacturers.


This project is part of the government's comprehensive "AX-Sprint" initiative, totaling 754 billion won, aimed at accelerating the transition to AI (AX). Of this, the Ministry of Health and Welfare plans to implement projects worth 45 billion won, including 28 billion won for welfare and 17 billion won for health. The health sector will focus on digital medical devices (8 billion won) and chronic disease management (9 billion won), among other areas.


AX-Sprint is a large-scale initiative in which 11 government ministries collaborate to support the release of AI application products that can be experienced by citizens in daily life and industry within one to two years.


In particular, in the healthcare sector, even when promising AI technologies are developed and receive approval from the Ministry of Food and Drug Safety, companies must still overcome difficult clinical validation and evaluation processes, as well as insurance registration—market entry barriers that are difficult for companies to address on their own. Overcoming these challenges is essential, as commercialization often requires a lengthy process.


This project will be conducted as a consortium between companies that possess AI-based digital medical devices at the post-approval market entry stage and hospital-level medical institutions that will actually use these devices. Selected consortia will receive broad support throughout 2026 and 2027 for multi-institutional clinical validation required at each stage of market entry, accumulation of real-world clinical data (RWD/RWE), and costs for economic evaluation. In addition, comprehensive support will be provided for marketing costs to help expand into new medical institutions and increase sales, thereby serving as a "commercialization expressway" that goes beyond research and development (R&D) to ensure actual market adoption.


Jung Eun-young, Director General for Health Industry Policy at the Ministry of Health and Welfare, stated, "We will actively support the resolution of difficulties that promising digital medical device companies have faced in the market entry process even after regulatory approval, and facilitate the rapid adoption of high-quality AI-based digital medical devices in clinical settings."



Applications for the project will be accepted online until 6:00 p.m. on April 24. Detailed announcements and application forms can be found on the website of the Korea Health Industry Development Institute.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing